Status:
COMPLETED
Clinical Outcomes of Ready-to-Use Parenteral Nutrition in Low Birth Weight Newborns in Colombia 2017-2023
Lead Sponsor:
Fundacion Clinica Valle del Lili
Collaborating Sponsors:
Baxter Healthcare Corporation
Conditions:
Very Low Birth Weight Infant
Eligibility:
All Genders
Up to 24 years
Brief Summary
The proposed study aims to assess the clinical outcomes of using ready-to-use parenteral nutrition, specifically Numeta G13E, compared to individualized parenteral nutrition in neonates with very low ...
Detailed Description
Introduction: Parenteral nutrition enhances nutrition in very low birth weight newborns (\<1500 g) who, due to gastrointestinal immaturity, experience delays in obtaining adequate nutrients enterally...
Eligibility Criteria
Inclusion
- Newborns admitted to the neonatal intensive care unit between March 2017 and March 2023
- Requirement for Parenteral Nutrition.
- Birth weight less than 1500 grams (very low birth weight).
Exclusion
- Patients transferred from another hospital with more than 24 hours of life.
- Incomplete follow-up (until 36 weeks corrected age or discharge).
- Major congenital anomalies.
Key Trial Info
Start Date :
March 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 31 2023
Estimated Enrollment :
284 Patients enrolled
Trial Details
Trial ID
NCT06200324
Start Date
March 1 2017
End Date
March 31 2023
Last Update
January 11 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fundación Valle del Lili
Cali, Valle del Cauca Department, Colombia